Bioadaptives Inc (PK) (BDPT) Quote

https://ih.advfn.com/stock-market/USOTC/bioadaptives-pk-BDPT/stock-news/94406412/form-10-q-quarterly-report-sections-13-or-15d

10-Q out!

Only a matter of time here.

https://www.otcmarkets.com/filing/html?id=17764951&guid=2xO-kp-vXMGvJth

LMFDO

I would imagine. Hopefully the new mgmt. will drive the price.

BB

Don’t see her around,
All the pumpers left
New promoters will arrive of course !

Did they hire CarJockey to blappity blap yet?

Big Benny (Long time no see y'all)

Pump and dump again?
SS not changed a while is the only good thing here
Everything else is BS

LFG!

Gee what is going on here? Haven't seen any news yet.

Nice!

Added

Bunch a false promises here, too bad they can't figure it out and make investors money

These people need to get the rag out and inform investors whats going on. Just looks like another deadbeat otc company swindling shareholders with false info from the past. Aint shit happening now as I see it.

Pdg ?? News??? 0x0 =00000 !!!!

Why would anyone take over this stock unless they have a plan?

The new CEO buying a bunch of stock would be a bright idea…

Re:”Maybe the new CEO will have some bright idea like mailing out product catalogs like good ole Sears. This new fandangled online purchasing like Amazon is just a fad........”

What are you ON, Man?

The company has 1,231,718,974 OS with a 1.25b AS. They publicly disclose they have minimal revenues and intend to raise money by offering more shares. The next significant news beyond some fluff product news release will likely be an 8k announcing an increase to the AS followed by an S-1 registration statement for a new offering. Those will cause a market correction to the share price in a downward direction.

Maybe the new CEO will have some bright idea like mailing out product catalogs like good ole Sears. This new fandangled online purchasing like Amazon is just a fad........

Here’s to hoping things improve!

Great to hear that. There is a big need for such products, if they really work and have high quality control standards.

new ceo and board member have me interested

Thank you. I already placed an order for the products. Loved these pills.

There is a description and apparent ability to purchase this product at

www.pluripain.com

Otherwise they list this contact info:

(877) 252 – 8282

info@bioadaptives.com

Some good soup?

SOMETHING IS COOKING .
I could smell it.😂

let's hope we get some kind of a recovery, will see

Those of us who've lost a metric ton of money here haven't forgotten...Sigh...

It's dead

Thank you. Appreciated.

https://flyingcbar.myshopify.com/collections/all

They developed a new website. I can no longer purchase this product called PluriPain. Does anyone here know where I can find this amazing PluriPain?

????? Dilution??? As 2 bill?
Fake society!

News ?????????

That would be nice, I was just expecting this New Management to do a little more. At least say something.

Good. Havn’t forgot about it enough to let me get my damn .0001s yet tho

wow 39 volume' looks like everyone has forgot about this failure

Hear, hear!

Good, this stock needs some serious help. Investors not happy about stock’s performance, straight up awful.

Either this guy is out of his mind to join BDPT or they have something really special we don’t know about it yet!
Wait game!
At least no dilution for a while now

https://menafn.com/1108279173/Investornewsbreaks-Bioadaptives-Inc-BDPT-Appoints-Car-Rental-Industry-Veteran-To-Its-Board-Of-Directors

Hopefully it only gets better from now on.

BDPT Welcomes Gimhana Dissanayake to Its Board of Directors...

This is more solid news for BDPT as a guy of this caliber would not be joining this team for something small in my opinion:

https://www.otcmarkets.com/stock/BDPT/news/story?e&id=2876656
BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors.

We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights.

LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leader in the health and wellness sector, today announces the appointment of Gimhana Dissanayake to its Board of Directors. Gimhana, who currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ), brings over two decades of comprehensive experience and a proven track record of strategic growth and operational excellence to BioAdaptives.

With an illustrious career that has spanned various leadership roles at Hertz, Gimhana is renowned for his strategic vision and leadership acumen. He has been instrumental in advancing the Hertz, Dollar and Thrifty brands, significantly enhancing their market presence and competitive edge. As the senior director of strategic partnerships, he spearheaded initiatives that fostered key alliances with Fortune 500 companies and drove substantial growth across 10 revenue verticals for North America. His efforts earned him the nickname “Founder of Canada” within Hertz, a testament to his successful expansion of the company’s market share in the region. His strategic prowess is a valuable asset that will undoubtedly benefit BioAdaptives.

Gimhana's educational background and extensive professional experience make him an invaluable addition to the BioAdaptives board. He holds an undergraduate degree from Oklahoma State University and an MBA from California State University, Sacramento. In addition, he has completed advanced executive education at Cornell University and the Wharton School of Business. This rich academic and professional foundation equips him with the knowledge and skills necessary to significantly contribute to Bioadaptive's growth and success.

“We are delighted to welcome Gimhana to our Board of Directors,” said Jim Keener, chairman of the board at BioAdaptives. “His exceptional contributions to the car rental industry and his strategic insight are precisely what BioAdaptives needs as we continue to innovate and expand our reach in the wellness sector. We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights.”

About BioAdaptives

BioAdaptives, Inc. develops and distributes natural herbal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; stress resistance; endurance; recovery from injury, illness, and exercise; and anti-aging properties. Our current dietary supplement formulations are carefully selected from the best sources worldwide, and proprietary methods are utilized to enhance the bioavailability of nutrients. Our products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, pain relief and improved appearance.

BioAdaptives' common shares trade in the OTC market under the symbol BDPT. None of the statements about our products have been approved by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Additional information can be found at www.shopbioadaptives.com or in our SEC filings.

Safe Harbor Statement

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the press release date, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date after the date of this press release.

Contact

Investor Relations
BioAdaptives, Inc.
(702) 659-8829
info@bioadaptives.com

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

v/r
Sterling

https://www.investorwire.com/newsarticle/?qmstory=5266682648393905

https://www.streetinsider.com/dr/news.php?id=23300472&gfv=1

lol. You mean the new story to lure the sheep in? Hahaha.

Bad bad bad 👎👎👎

More possible now then before

Great. Can we get out of trips now?